INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/22/2026
Back to search
Official data from USPTO
DORIANEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/23/2026
Trademark type
Word
Nice classes
5
Filing date
03/01/2018
Registration date
02/05/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2025
Last transaction
04/23/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
85
Owner location
ES
Examiner
COLLOPY, DIANE PATRICIA
Law office
P10
Current location
TMO LAW OFFICE 137
Holders and representatives
Holders
LABORATORIOS FARMACEUTICOS; ROVI, S.A.
Representatives
Kevin Hartley Trust Tree Legal, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsantibioticsanalgesicsanestheticsamino acids for medical useantisepticstranquilizerscollyriumsdigestives for pharmaceutical uselaxativesnarcotics; chemical products for medical usebeing pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headache; sedatives; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; contraceptives; vaccinessyringesvialscartridges or carpules and ampoules for medical purposes containing pharmaceutical products in the nature of antipsychotics; pharmaceutical implants for delivering insulin; sustained release medicine implants for delivering contraceptives; oncological preparations being pharmaceuticals for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal diseases; preparations for the treatment of allergiesfor the treatment of the skinthrombosiscoagulation diseasesinfectionsflupain and inflammation
Publications
History of USPTO decisions and trademark events.
29 publications found
C71T
CANCELLED SECTION 71
08/22/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/08/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/19/2019
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
05/31/2019
XXCR
GENERIC MADRID TRANSACTION CREATED
05/31/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/05/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/20/2018
PUBO
PUBLISHED FOR OPPOSITION
11/20/2018
GPNX
NOTIFICATION PROCESSED BY IB
11/17/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/31/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/31/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/31/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/10/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2018
RFNT
REFUSAL PROCESSED BY IB
07/27/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/06/2018
RFRR
REFUSAL PROCESSED BY MPU
07/06/2018
MAFR
APPLICATION FILING RECEIPT MAILED
06/26/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/23/2018
CNRT
NON-FINAL ACTION WRITTEN
06/22/2018
DOCK
ASSIGNED TO EXAMINER
06/22/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/22/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/21/2018
Continuous trademark protection
Get notified about every new filing that threatens DORIANEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.